Quantification of Retinal Neural Loss in Patients with Neuromyelitis Optica and Multiple Sclerosis with or without Optic Neuritis Using Fourier-Domain Optical Coherence Tomography


Autoria(s): Monteiro, Mario L. R.; Fernandes, Danilo B.; Apostolos-Pereira, Samira L.; Callegaro, Dagoberto
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

05/11/2013

05/11/2013

2012

Resumo

PURPOSE. We compared retinal nerve fiber layer (RNFL) and macular thickness measurements in patients with multiple sclerosis (MS) and neuromyelitis optica (NMO) with or without a history of optic neuritis, and in controls using Fourier-domain (FD) optical coherence tomography (OCT). METHODS. Patients with MS (n = 60), NMO (n = 33), longitudinal extensive transverse myelitis (LETM, n = 28) and healthy controls (n = 41) underwent ophthalmic examination, including automated perimetry, and FD-OCT RNFL and macular thickness measurements. Five groups of eyes were compared: MS with or without previous optic neuritis, NMO, LETM, and controls. Correlation between OCT and visual field (VF) findings was investigated. RESULTS. With regard to most parameters, RNFL and macular thickness measurements were significantly smaller in eyes of each group of patients compared to controls. MS eyes with optic neuritis did not differ significantly from MS eyes without optic neuritis, but measurements were smaller in NMO eyes than in all other groups. RNFL (but not macular thickness) measurements were significantly smaller in LETM eyes than in controls. While OCT abnormalities were correlated significantly with VF loss in NMO/LETM and MS, the correlation was much stronger in the former. CONCLUSIONS. Although FD-OCT RNFL and macular thickness measurements can reveal subclinical or optic neuritis-related abnormalities in NMO-spectrum and MS patients, abnormalities are predominant in the macula of MS patients and in RFNL measurements in NMO patients. The correlation between OCT and VF abnormalities was stronger in NMO than in MS, suggesting the two conditions differ regarding structural and functional damage. (ClinicalTrials.gov number, NCT01024985.) Invest Ophthalmol Vis Sci. 2012;53:3959-3966) DOI:10.1167/iovs.11-9324

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP, Sao Paulo, Brazil [2009/50174-0]

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brasilia, Brazil [306487/2011-0]

CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasilia, Brazil)

Identificador

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ROCKVILLE, v. 53, n. 7, supl. 1, Part 1, pp. 3959-3966, JUN, 2012

0146-0404

http://www.producao.usp.br/handle/BDPI/41632

10.1167/iovs.11-9324

http://dx.doi.org/10.1167/iovs.11-9324

Idioma(s)

eng

Publicador

ASSOC RESEARCH VISION OPHTHALMOLOGY INC

ROCKVILLE

Relação

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Direitos

closedAccess

Copyright ASSOC RESEARCH VISION OPHTHALMOLOGY INC

Palavras-Chave #NERVE-FIBER LAYER #EXTENSIVE TRANSVERSE MYELITIS #AXONAL LOSS #DIAGNOSTIC-CRITERIA #AUTOMATED PERIMETRY #VISUAL-FIELD #TIME-DOMAIN #THICKNESS #PATHOLOGY #ATROPHY #OPHTHALMOLOGY
Tipo

article

original article

publishedVersion